2016 International Congress Archives - Page 148 of 207

Safety and clinical effects of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson’s disease (PD): 81 to 130 weeks follow-up

B.J. Snow, E. Mulroy, M. Simpson, L. Macdonald, A. Bok, K. Taylor, J. Han, K. Durbin (Auckland, New Zealand)
Safety and efficacy of escalating doses of incobotulinumtoxinA (400-800U): Increasing improvements in disability due to multifocal upper- and lower-limb spasticity

J. Wissel, D. Bensmail, B. Rubin, A. Scheschonka, O. Simon, D.M. Simpson (Berlin, Germany)
Safety and efficacy of pardoprunox for patients with Parkinson’s disease: A meta-analysis

N. Elsagheer, H. Ahmed, A. Attia, K. Awad, E. Ezzat, M. Abd Elaleem Aziz, A. Negida (Beni Suef, Egypt)
Safety and tolerability of inhaled levodopa (CVT-301) administered to Parkinson’s disease patients with motor fluctuations

R. Pahwa, P. LeWitt, A. Corbin, R. Batycky, H. Murck (Kansas City, KS, USA)
Safety of deep brain stimulation for movement disorders: A single-centre long-term standardized recording and analysis

C. Bagella, D. Calandrella, G. Zorzi, G. Messina, F. Carella, A. Franzini, C.E. Marras, N. Nardocci, L.M. Romito (Milan, Italy)
Safety of nelotanserin in a randomized placebo-controlled phase 2 study

W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, S. Piscitelli, M. Sanchez, W. Shanahan (New York, NY, USA)
Safety of opicapone in fluctuating Parkinson’s disease patients: Results of the 1-year extension of study BIPARK I

A. Santos, J. Ferreira, A. Lees, F. Stocchi, O. Rascol, N. Lopes, H. Gama, J.F. Rocha, P. Soares-da-Silva (Porto, Portugal)
Safety, pharmacokinetics, and efficacy of levodopa prodrug ONO-2160/CD: A study in patients with Parkinson’s disease

M. Nomoto, M. Nagai, N. Nishikawa, Y. Kagamiishi, K. Yano, M. Akisada, S. Saito, M. Yuba, A. Takeda (Tohon Ehime, Japan)
Saliva swallowing frequency measured using 24-hours ambulatory impedance-pH monitoring in patients with Parkinson’s disease and drooling

J.G. Kalf, S. Scholten, W. Hopman (Nijmegen, Netherlands)
Same cerebellar atrophy pattern in hyper- and hypokinetic movement disorders due to mitochondrial cytopathy

S.R. Schreglmann, F. Riederer, C. Ganos, G. Kägi, D. Waldvogel, U. Hidding, E. Krasemann, C.R. Baumann, K.P. Bhatia, H.H. Jung, L. Michels (London, United Kingdom)
Sarcopenia and dynapenia in patients with parkinsonism

E. Cassani, E. Cereda, G. Pinelli, L. Iorio, A. Valentino, C. Pusani, V. Ferri, C. Bolliri, M. Pasqua, G. Frazzitta, M. Barichella, G. Pezzoli (Milano, Italy)
Scores and dimensions to assess cognitive impairment in Parkinson’s disease

I. Liepelt-Scarfone, S. Gräber, A. Pilotto, D. Blum, M. Fruhmann Berger, D. Berg (Tübingen, Germany)
Screening for neuropsychiatric symptoms in Parkinson’s disease

M.J. Barrett, S.A. Sperling, B.B. Shah, J.L. Flanigan, G.F. Wooten, M.B. Harrison, C.A. Manning (Charlottesville, VA, USA)
Screening for SLC25A46 mutations in familial and sporadic ataxic patients

S. Efthymiou, C. Bettencourt, H. Houlden (London, United Kingdom)
Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia

H. Bejr-Kasem, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Perez-Perez, J. Marin-Lahoz, B. Pascual-Sedano, S. Martínez-Horta, J. Kulisevsky (Barcelona, Spain)
Seated balance is impaired in patients with idiopathic cervical dystonia

J. De Pauw, R. Mercelis, A. Hallemans, G. Van Gils, S. Truijen, P. Cras, W. De Hertogh (Antwerp, Belgium)
Selective activation of excitatory cell groups in the medial medulla differentially affects spatial-temporal gait parameters

A. Worley, S. Luks, V. VanderHorst (Boston, MA, USA)
Selective M4 antagonism potentiates L-DOPA-induced dyskinesia in MPTP-treated common marmosets

D. Klisko, R. Fisher, L. Lincoln, P. Jenner, S. Rose (London, United Kingdom)
Selenotranscriptomic analyses identify signature selenoproteins in brain regions in a mouse model of Parkinson’s disease

J.Y. Wang, X. Zhang, Y.L. Ye, H.H. Fan, H.M. Wu, W.H. Cheng, J.H. Zhu (Wenzhou, People's Republic of China)
Self-perception of daily performance in relation to motor performance in advanced Parkinson’s disease – Case studies

J. Jansa, B. Piks, D. Flisar, M. Gregoric Kramberger, Z. Pirtosek (Ljubljana, Slovenia)
Self-perception of vocal handicap in Parkinson’s disease

A.K. Silbergleit, J. Wall, L. Schultz, J. Peacock, P.A. LeWitt (West Bloomfield, MI, USA)
Self-reported cognitive complaints and neuropsychological performance in idiopathic REM sleep behavior disorder

P.A. Bourgouin, F. Escudier, L. Bernier-Lalonger, R.B. Postuma, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)
Sensitivity of people with Parkinson’s to different intensities of emotions (SPiEs)

J. Wincenciak, D.J. Burn, L.S. Delicato (Newcastle upon Tyne, United Kingdom)
Sensor based gait analysis: Diagnostic application for apomorphine titration

F. Marxreiter, H. Gassner, J. Barth, J. Schlachetzki, C. Thun, D. Volc, J. Winkler, B. Eskofier, J. Klucken (Erlangen, Germany)
Sensor-based motor state detection in Parkinson’s disease to approach personalized therapy delivery

L.P. Roncoroni, M. Scholten, I. Hanci, A. Gharabagi, D. Weiss (Tübingen, Germany)
Sensorimotor gray matter changes in professional brass players with and without Embouchure dystonia

T.A. Mantel, C. Dresel, E. Altenmüller, A. Jochim, G. Gora-Stahlberg, C. Zimmer, B. Haslinger (Munich, Germany)
Sensorimotor impairments and the excitability of spinal cord in lead intoxicated rat during development and a potent restorative effect of curcumin

H. Benammi, O. El Hiba, H. Gamrani (Marrakesh, Morocco)
Sensory and motor aspects of rhythmic entrainment in Parkinson’s disease

E.S. te Woerd, R. Oostenveld, F.P. de Lange, P. Praamstra (Nijmegen, Netherlands)
Sensory gating and inhibition in dystonia

E. Antelmi, R. Erro, L. Rocchi, R. Liguori, M. Tinazzi, J. Rothwell, K. Bhatia (Bologna, Italy)
Sensory tricks in cervical dystonia

A. Gündüz, A.D. Elmali, G.S. Koçak, N. Uzun Adatepe, F. Karaali-Savrun, M. Kiziltan (Istanbul, Turkey)
Sensory tricks in primary blepharospasm and cervical dystonia

S. Pandey, G. Soni, N. Sarma (New Delhi, India)
Serum brain-derived neurotrophic factor as an indication of disease state in parkinsonism and RBD

K. Csencsits-Smith, J. Suescun, A. Gonzalez, A. Actor, M. Schiess (Houston, TX, USA)
Serum level of vitamin D3 in patients with neurodegenerative diseases compared to healthy adults and its correlation with the years spent from the initial diagnosis

A.N. Taravari (Skopje, Macedonia)
Serum levels of polychlorinated biphenyls, CYP2B6 and neurodegenerative disease in the Faroe Islands

L.L. Farrell, E. Nosova, S. Bech, I. Guella, M.J. Farrer, M.S. Petersen (Vancouver, BC, Canada)
Severe striatal and pallidal atrophy in early disease stages of X-linked dystonia-parkinsonism

H. Hanßen, M. Heldmann, R.L. Rosales, A. Domingo, A. Münchau, T. Bäumer, D. Rasche, V. Tronnier, T.F. Münte, L.V. Lee, C. Klein, N. Brüggemann (Lübeck, Germany)
sFIDA: A sensitive diagnostic assay for quantification of α-synuclein aggregates

T. Bujnicki, C. Zafiu, O. Bannach, D. Willbold (Jülich, Germany)
Shape and volume abnormalities relate to motor abilities in idiopathic rapid eye movement sleep behavior disorder

S. Rahayel, C. Bedetti, R.B. Postuma, J. Montplaisir, S. Brambati, J. Carrier, O. Monchi, J.F. Gagnon (Montreal, QC, Canada)
Significant improvement of adult-onset dystonia with cannabinoids-based oromucosal spray

M. Aguilar, S. Romero, L. Molina Porcel, P. Pastor (Terrassa, Spain)
Simultaneous symptomatic onset of Parkinson’s disease and myasthenia gravis

P. Kumar, T.M. Biller, A.M. Kurzweil, K. Kiprovski, J.E. Fleisher (New York, NY, USA)
Single unit activity of globus pallidus during voluntary movements in patients with cervical dystonia

A.S. Sedov, A.A. Tomskiy, A.V. Dekopov, R.S. Medvednik, S.V. Zvorikina (Moscow, Russia)
Single unit activity of medial thalamus during goal-directed motor and cognitive behavior in patients with cervical dystonia

U.N. Semenova, D.A. Devetiarov, R.S. Medvednik, A.S. Sedov (Moscow, Russia)
Single versus multiple microelectrode recordings (MER) in STN-DBS-surgery for PD: A randomized double-blind controlled trial

S. Bjerknes, A.E. Konglund, E. Ilstad, U. Pham, M. Skjelland, E. Dietrichs, M. Toft (Oslo, Norway)
Single-subject FDG PET patterns and cognitive dysfunctions in Parkinson’s disease

A. Pilotto, E. Premi, S.P. Caminiti, L. Presotto, R. Turrone, A. Alberici, B. Paghera, B. Borroni, D. Perani, A. Padovani (Brescia, Italy)
Sleep deprivation (SD) amongst carers of patients with Parkinson’s disease (PD)

D. Kulatunga, H. Avery, A.K. Chatterjee, A. Plowman, J. Caffrey, S. Pradhan (Reading, United Kingdom)
Sleep disordered breathing in patients of Parkinson’s disease with REM sleep behavior disorder

R. Yadav, N. Kamble, J. Saini, K. Kumar, P.K. Pal (Bangalore, India)
Sleep disorders in progressive supranuclear palsy

B. Muinjonov, E. Giyaziddinova (Tashkent, Uzbekistan)
Sleep in essential tremor patients: A polysomnographic study

O. Dogu, S. Ozal, H. Kaleagasi (Mersin, Turkey)
Sleep motor activity in amyotrophic lateral sclerosis

M. Puligheddu, P. Congiu, D. Aricò, F. Rundo, F. Marrosu, G. Gioi, E. Costantino, G. Borghero, M.L. Fantini, R. Ferri (Monserrato, Italy)
Sleep related disorders in subtypes of patients with Parkinson’s disease in the Tomsk region, Russia

M.A. Nikitina, I.A. Zhukova, V.M. Alifirova, N.G. Zhukova, O.P. Izhboldina, J.S. Mironova, M.A. Titova, N.G. Brazovskaya, S.E. Sukhanov (Tomsk, Russia)
Smell perception and judgement in PD patients: Results of a study designed, conducted, analysed and reported by PD patients

J. Stamford (London, United Kingdom)
SMPD1 mutations, acid-sphingomyelinase activity and α-synuclein accumulation in Parkinson’s disease

Z. Gan-Or, V. Mallett, O. Tavassoly, Y. Dauvilliers, C. Leblond, A. Ambalavanan, S. Laurent, S. Strong, D. Spiegelman, A. Dionne-Laporte, C. Liong, O. Levy, S. Fahn, C. Waters, P. Mazzoni, S. Kuo, W. Chung, B. Ford, K. Marder, U. Kang, P. Wolf, P. Oliva, X. Zhang, L. Clark, P. Dion, E. Fon, N. Dupre, G. Rouleau, R. Alcalay (Montreal, Canada)
Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism

F. Krismer, B. Pinter, C. Müller, P. Mahlknecht, M. Nocker, E. Reiter, A. Djamshidian-Tehrani, S.M. Bösch, G.K. Wenning, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)
Social cognition assessment in progressive supranuclear palsy: The cognitive interface with frontotemporal dementia

E.P.F. Resende, P. Caramelli, F.E.C. Cardoso, H.C. Guimarães, M. Hornberger, M. Bertoux, A.L. Teixeira, L. Cruz de Souza (Belo Horizonte, Brazil)
SOD1 aggregation: A pathological link between Parkinson’s disease and amyotrophic lateral sclerosis?

B.G. Trist, K.M. Davies, S. Genoud, V. Smoothy, G.M. Halliday, S. Roudeau, A. Carmona, L. Perrin-Verdugier, R. Ortega, K.L. Double (Sydney, Australia)
Sodium butyrate attenuates rotenone-induced neurodegeneration via enhancing autophagy and preventing α-synuclein aggregation

L. Liu, C. Han, K. Ma, X. Xu, J. Huang, N. Xiong, T. Wang (Wuhan, People's Republic of China)
Sonographic investigation of Pisa syndrome in Parkinson’s disease

J. Shiraishi, T. Okazaki, M. Mizuba, K. Kajiwara, S. Saeki, R. Matsugaki, T. Takei, T. Uozumi (Fukuoka, Japan)
Spastic gait and mechanical energy recovery in children with hereditary spastic paraplegia

V. Maltese, S. Klebe, A. Marzegan, M. Dipaola, J. Volkmann, C.A. Frigo, P. Cavallari, I.U. Isaias (Wuerzburg, Germany)
SPAsticity in PractiCE (SPACE) – An international, observational study of botulinum toxin type A in spasticity

J. Wissel, J. Harriss, O. Simon, K. Sternberg, N. Roche, C. Cantú-Brito, S. Khatkova, P. Säterö (Berlin, Germany)
Spatial accuracy and reliability of the Microsoft Kinect V2 in the assessment of joint movement in comparison to marker-based motion capture (Vicon)

K. Otte, B. Kayser, S. Mansow-Model, A.U. Brandt, J. Verrel, T. Schmitz-Hübsch (Berlin, Germany)
Specific in-patient’s rehabilitation improves postural and gait instability in Huntington’s disease

L. Brabcová, J. Roth, O. Horácek, M. Kolárová, H. Bozková, J. Rusz, P. Košková, K. Lísalová, F. Jancok, J. Klempír, E. Ruzicka, H. Brozová (Beroun, Czech Republic)
Specificity and sensitivity of F-waves parameters in diagnosis of RLS/WED

P. Congiu, M.L. Fantini, G. Milioli, P. Tacconi, M. Figorilli, G. Gioi, B. Pereira, F. Marrosu, L. Parrino, M. Puligheddu (Monserrato, Italy)
Spectral analysis of rapid eye movement (REM) sleep as a potential marker of neurodegenerative disease in REM sleep behavior disorder

J. Rodrigues Brazète, J.F. Gagnon, R.B. Postuma, P.A. Bourgouin, D. Petit, J. Montplaisir (Montreal, QC, Canada)
Spectrum of acute movement disorders in a pediatric movement disorder clinic; Malaysian experience

T.A. Tajudin (Johor, Malaysia)
Speech 10 years post bilateral STN-DBS for Parkinson’s disease

E. Tripoliti, P. Mahlknecht, L. Zrinzo, M. Hariz, T. Foltynie, J. Candelario, P. Limousin (London, United Kingdom)
Speech and voice range profile in patients with Parkinson’s disease with deep brain stimulation: Preliminary data

G.L.A. Diaféria, A.E. Dias, M.J. Carvalho, R. Cury, E.R. Barbosa, E.T. Fonoff (São Paulo, Brazil)
Speech evaluation in Parkinson’s disease using a transcribed version of the Frenchay dysarthria assessment

M. Löhle, A. Zenker, R. Jäckel, C. Bosredon, R. Hoffmann, A. Storch (Rostock, Germany)
Speech prosody impairment predicts cognitive decline in Parkinson’s disease

I. Rektorova, J. Mekyska, E. Janousova, M. Kostalova, M. Mrackova, I. Eliasova, D. Berankova, R. Marecek (Brno, Czech Republic)
Speed and severity of toxicity induced by pre-formed α-synuclein fibrils in rat brain is enhanced by α-synuclein overexpression

P. Thakur, L. Breger, B. Mattsson, K. Luk, V.M. Lee, J. Trojanowski, A. Björklund (Lund, Sweden)
Spinal cord stimulation improves freezing of gait in Parkinson’s disease in chronic implanted stn-dbs patients: A case report

C.O. Souza, C.P. Souza, A.L. Pardini, D. Boari, L.A. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)
Spinal fluid biomarkers for multiple system atrophy – A pilot study

W. Singer, A. Schmeichel, D.M. Goldstein, J.D. Schmelzer, A.D. Zeller, T.L. Gehrking, P.A. Low (Rochester, MN, USA)
Spinocerebellar ataxia 17: First observation in Russia

S.A. Klyushnikov, D.A. Prikhodko, N.Y. Abramycheva, M.Y. Krasnov, S.N. Illarioshkin (Moscow, Russia)
Sporadic cerebellar ataxia associated with hypogonadotropic hypogonadism and PNPLA6 gene mutation. Case report in a Brazilian patient

H.A.G. Teive, C.L. Boguszewski, S. Raskin, C. Buck, S.B. Seminara (Curitiba, Brazil)
Stabilometry characteristics as objective Parkinson’s disease progression biomarkers

I.V. Miliukhina, T.V. Sergeev, E.V. Gracheva, A.V. Kudrevatykh, M.D. Didur (Saint-Petersburg, Russia)
Stage dependent alteration of cortical excitability in patients with hepatic encephalopathy

S.J. Groiss, M. Butz, T. Baumgarten, N.D. Füllenbach, D. Häussinger, A. Schnitzler (Düsseldorf, Germany)
Staging and clinical correlates of cortical thinning in Parkinson’s disease

H. Wilson, F. Niccolini, C. Pellicano, P. Piccini, M. Politis (London, United Kingdom)
Staging of cognitive impairment: Validation of a novel cognitive score with [¹⁸F]FDG-PET

D. Blum, M. Reimold, W. Maetzler, C. la Fougère, G. Reischl, D. Berg, I. Liepelt-Scarfone (Tübingen, Germany)
Standardized assessment of camptocormia in idiopathic Parkinson’s disease

T. Schmidt, G. Ebersbach, G. Doreen (Beelitz-Heilstätten, Germany)
Statistical aspects when exploring the association between change in body mass index (BMI), UPDRS scores and survival in the NET PD long-term study-1

A. Perez, A.M. Wills, J. Wang, X. Su, J. Morgan, S.S. Rajan, M. Leehey, G.M. Pontone, K.L. Chou, C. Umeh, Z. Mari, J. Boyd, For the NINDS NET-PD Investigators (Austin, TX, USA)
Status of NPF-QII after six years: Updates to the dataset

F. Cubillos, E.C. Nelson, T. Simuni, C. Marras, M. Rafferty, T. Davis, P. Schmidt (Miami, FL, USA)
STEADY-PD III. A phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson’s disease. Baseline characteristics of the enrolled cohort

T. Simuni, K.M. Biglan, J. Lowell, K. Hodgeman, B. Greco, R. Rockhill, D. Oakes (Chicago, IL, USA)
Stereotactic pallidotomy for Parkinson’s disease in El Salvador: One year follow up

S.L. Peña, R.E. Amaya (San Salvador, El Salvador)
Stereotactic surgery targeting on ventral oral posterior/ventral intermediate (Vop/Vim) in patients with upper limb dystonia: Neuronal activity and optimal effective site

N. Murase, M. Matsuhashi, K. Maeda, S. Kawarazaki, M. Nakamura, T. Thukahara, H. Hirabayashi (Kyoto City, Japan)
Stiff person syndrome

P. Dosekova, G. Krastev, J. Haring, R. Lackovic (Trnava, Slovakia (Slovak Republic))
Stiff person syndrome: Case series

E. Sasse, G. Amorelli, M. Spitz, C.S.B. Germano, L.F. Vasconcellos (Rio De Janeiro, Brazil)
Stimulation of the globus pallidus internus in the treatment of Parkinson’s disease: Long-term results of a monocentric follow-up

M.L. Lachenmayer, C. Bettschen, I. Debove, J. Muellner, C. Bernasconi, J.M. Burgunder, J.K. Krauss, M. Oertel, A. Kaelin, C. Pollo, M. Schuepbach (Bern, Switzerland)
STN-DBS in Parkinson’s disease with early motor complications – A 10 year follow-up

J. Muellner, F. Pineau, D. Maltête, J.L. Houeto, M.L. Welter, S. Navarro, P. Cornu, C. Bernasconi, Y. Agid, M. Schuepbach (Bern, Switzerland)
Strategies for a high quality data in an observational longitudinal study: Enroll-HD experience

N. Gonçalves, D. Abreu, R. Lobo, J. Giuliano, T. Mestre, J.J. Ferreira, C. Fitzer-Attas, B. Landwehrmeyer, C. Sampaio (Lisbon, Portugal)
Strategies to improve drug development efficiency through regulatory interactions, minimizing the placebo effect and improving data integrity within a phase 3 study of tozadenant in Parkinson’s disease patients with motor fluctuations (TOZ-PD)

F. Kerwood, C. Kenney, K. Kieburtz, W. Olanow, C. Resburg, J. Krishnaswami, S. Bandak (San Francisco, CA, USA)
Strengths and weaknesses of patient-reported outcomes following DBS surgery: Comparing clinician, patient, and caregiver assessments

L. Shahgholi, W. Deeb, K. Foote, A. Shukla, U. Akbar, J.P. Rossi, S. De Jesus, M.S. Okun (Gainesville, FL, USA)
Striatal and pedunculopontine nucleus diffusion tensor imaging in cervical dystonia

K. Mente, A. Holmes, D. Urbano, M. Hallett, S.G. Horovitz (Bethesda, MD, USA)
Striatal molecular alterations in Huntington’s disease gene expansion carriers: A systematic review and meta-analysis of PET studies

F. Niccolini, G. Pagano, P. Fusar-Poli, A. Wood, L. Mrzljak, C. Sampaio, M. Politis (London, United Kingdom)
Striatal PDE10 expression in Parkinson’s disease (PD) and healthy controls using [¹⁸F]MNI-659 PET imaging

D.S. Russell, D.L. Jennings, O. Barret, G.D. Tamagnan, D. Alagille, J.P. Seibyl, K.L. Marek (New Haven, CT, USA)
Striatal postsynaptic dysfunction in X-linked dystonia-parkinsonism is associated with disease progression

N. Brüggemann, R.L. Rosales, J.L. Waugh, A.J. Blood, A. Domingo, M. Heldmann, R.D. Jamora, A. Münchau, L.V. Lee, I. Buchmann, C. Klein (Lübeck, Germany)
STRONG VOICE: Design of a multisite, open-label, longitudinal registry for patients with neurogenic dysphonia/dysphagia treated with vocal fold augmentation

K.D. Sethi, A. Verma, C.A. Rosen, C.H. Adler, C.J. Bassich, T.L. Carroll, M.D. Stacy (Raleigh, NC, USA)
Structural and connectivity changes after botulinum neurotoxin therapy in blepharospasmus and hemifacial spasm

C.V. Chirumamilla, G. Deuschl, K.E. Zeuner, M. Muthuraman, S. Groppa (Mainz, Germany)
Structural and functional brain network alterations in psychogenic dystonia

E. Sarasso, F. Agosta, A. Tomic, S. Basaia, M. Svetel, G. Mandic-Stojmenovic, M. Copetti, V.S. Kostic, M. Filippi (Milan, Italy)
Structural and functional signature of primary orthostatic tremor

C. Gallea, T. Popa, E. Roze, S. Lehéricy, S. Meunier, M. Vidailhet (Paris, France)
Structural connectivity networks in prodromal and clinical Huntington’s disease

C. Sanchez-Castañeda, H. Baggio, U. Sabatini, F. Squitieri, C. Junque (Barcelona, Spain)
Structural organization of the brain connectome in patients with psychogenic dystonia

S. Basaia, F. Agosta, A. Tomic, E. Sarasso, M. Svetel, S. Galantucci, V.S. Kostic, M. Filippi (Milano, Italy)
STUB1/CHIP mutations cause Gordon Holmes syndrome as part of widespread multisystemic neurodegeneration: Evidence from novel mutations

S.N. Hayer, K. Smets, B. Bender, T. Deconinck, S. Züchner, L. Schöls, R. Schüle, P. De Jonghe, J. Baets, M. Synofzik (Tübingen, Germany)
Study of striatal dopamine transporter function in Alzheimer’s disease with parkinsonism

T. Yamamoto, A. Miyake, K. Ikeda, T. Furuya, T. Mitsufuji, Y. Ito, T. Sasaki, K. Takahashi, N. Tamura, I. Matsunari, A. Nobuo (Iruma-gun, Japan)
Study on association between physical and genetics role in essential tremor – A case control study

K. Kalimuthu, C. Ramachandran, M. Kadarkarai, V. Savariar (Coimbatore, India)
Sub-acute rapidly progressive cerebellar ataxia – A case of JC virus associated granule cell neuronopathy (GCN)

V.K. Palmadottir, J.A. Gold, N. Vora, C.W. Kilbane (Stanford, CA, USA)
Subcutaneous apomorphine reduces OFF time and dyskinesias and improves quality of life in Parkinson’s disease (PD) – 5-year follow-up of patients in Greece

G.A. Tagaris, A. Skafida, D. Athanasopoulos, E. Trachani, S. Tsiara (Athens, Greece)
Subjective report does not predict objective swallow impairment in atypical Parkinsonian syndromes

L. Shahgholi, S. De Jesus, A. Paterson, W. Deeb, N.R. McFarland, K. Hegland (Gainesville, FL, USA)
Substantia nigra α4β2 nicotinic cholinergic receptor expression correlates with tremor in Parkinson’s disease

M. Muller, R. Albin, N. Bohnen (Ann Arbor, MI, USA)
Substantia nigra hyperechogenicity in Mexican patients with Parkinson’s disease

C.Y. Rodriguez-Garza, A. Anaya-Escamilla, R. Pinales-Razo, I. Estrada-Bellmann, C.R. Camara-Lemarroy (Monterrey, Mexico)
Substantia nigra hyperechogenicity in Parkinson´s disease motor phenotypes

T. Toomsoo, A.H. Pool, I. Liepelt–Scarfone, L. Kadastik-Eerme, T. Asser, D. Berg, P. Taba (Tallinn, Estonia)
Substantial motor and non-motor symptoms in children and adults with classical galactosemia and organic acidurias

A. Kuiper, M.A. Coenen, W. Eggink, M.A.J. Tijssen, T.J. De Koning (Groningen, Netherlands)
Subthalamic deep brain stimulation vs. intraduodenal levodopa infusion: A long-term retrospective comparative study

A. Merola, A.J. Espay, A. Romagnolo, A. Bernardini, M. Rosso, K.J. Espay, L. Rizzi, M. Zibetti, M. Lanotte, L. Lopiano (Torino, Italy)
Subthalamic neurons encode reward hypersensitivity and loss hyposensitivity in Parkinson’s patients with impulse control disorders

P.J. Rossi, A. Gunduz, M.S. Okun (Gainesville, FL, USA)
Subthalamic nucleus activity during virtual reality provoked lower limb freezing in a patient with Parkinson’s disease and freezing of gait

M.J. Georgiades, M. Gilat, J.M. Shine, J. McMaster, N. Mahant, S.J.G. Lewis (Sydney, Australia)
Subthalamic nucleus deep brain stimulation modulate catecholamine levels with significant relations to clinical outcome after surgery in patients with Parkinson’s disease

T. Yamamoto, T. Uchiyama, Y. Higuchi, M. Asahina, S. Hirano, Y. Yamanaka, S. Kuwabara (Chiba, Japan)
Subtle sensory abnormalities in patients with segmental and cervical dystonia detected by quantitative sensory testing

L. Paracka, F. Wegner, C. Blahak, M. Abdallat, M. Karst, D. Dressler, J.K. Krauss (Hannover, Germany)
Successful DBS: Doctors happy, patients not – Why?

M.H. Strothjohann, B. Holzinger, G.A. Fuchs, F. Weber (Bad Camberg, Germany)
Successful treatment of movement disorders after resection of midbrain cavernous malformations: Report of two cases

A. Smolanka, V. Smolanka, K. Karpinska, M. Dovhanych, T. Havryliv (Uzhhorod, Ukraine)
Suggested criteria for patient selection for therapy with carbidopa/levodopa enteral suspension (CLES)

R.L. Rodriguez, T. Green, F. Rossi, A. Khaku, J. Slevin (Orlando, FL, USA)
Suggested protocol for electroconvulsive therapy for depression in a Parkinson’s disease patient with a deep brain stimulator: A case report

K. Dashtipour, M. Pereau, D. Trenkle, C. Osorio, K. Stoletniy (Loma Linda, CA, USA)
Suicide attempts and Huntington’s disease: Perseveration, not just impulsivity

O.C. Roman, J.G. Stovall, D.O. Claassen (Nashville, TN, USA)
Supplement use in PD is associated with delayed initiation of dopaminergic therapy

L. Chahine, S. Xie, K. Smith, C. Scordia, R. Purri, C. Linder, J. Duda, N. Dahodwala (Philadelphia, PA, USA)
Suppression of dyskinesia in Parkinson’s disease by electrical stimulation of dorsal subthalamic nucleus tissue

H.A.C. Wark, G.H. Duffley, C.R. Butson, L.E. Schrock (Salt Lake City, UT, USA)
Surgical replacement of implantable pulse generators in deep brain stimulation: Adverse events and risk factors in a multicenter cohort

E. Jiltsova, A. Fytagoridis, T. Heard, J. Samuelsson, P. Zsigmond, S. Skyrman, T. Skoglund, T. Coyne, P. Silburn, P. Blomstedt (Uppsala, Sweden)
Survey of prodromal symptoms of Parkinson’s disease in Japan

M. Yogo, M. Morita, M. Suzuki (Katsushika-ku, Japan)
Survey of telemedicine use among MDS members

A. Hassan, E.R. Dorsey, E. Cubo, C.G. Goetz, B.R. Bloem, M. Guttman, S.L. Heath, M. Katz, M. Spinder, C.M. Tanner, Z. Mari, A. Pantelyat, J.A. Bajwa, N.B. Galifianakis, E.M. Gatto (Rochester, MN, USA)
Survival and risk of mortality of synucleinopathies: A 15 years population-based study (1991 – 2005)

R. Savica, J. Bower, C. Hagen, A.J. Eric, M.M. Mielke (Rochester, MN, USA)
Sustained effects of cerebellar transcranial direct current stimulation in patients with ataxia: A randomized, double blind, sham-controlled study

V. Dell'Era, A. Benussi, M. Cosseddu, A. Padovani, B. Borroni (Brescia, Italy)
Swallowing difficulties in patients with Parkinson’s disease and Parkinsonian syndromes

Y.O. Trufanov (Kyiv, Ukraine)
Swallowing disorders characteristics and the relation to cognitive level, disease duration and disease severity in patients with Huntington’s disease

Y. Manor, D. Shpunt, N. Avniel, S. Assa, Y. Torner, A. Gad, A. Ezra, J. Knaani, A. Socher, Y. Oestriecher-Kedem, T. Gurevich (Tel Aviv, Israel)
Swallowing in individuals with Parkinson’s disease: A study of FEES

A. Ayres, M.R. Olchik, C.R.M. Rieder, G.P. Jotz (Porto Alegre, Brazil)
Sweet spot of antidystonic effect in pallidal neurostimulation

M.M. Reich, F. Lange, R. Nijlunsing, J. Roothans, M. Rezhkov, M. Åström, N. Pozzi, F. Steigerwald, R. Nickl, C. Matthies, J. Volkmann (Wuerzburg, Germany)
Switching double-blind opicapone, entacapone or placebo to open-label opicapone: Efficacy results of the 1-year extension of study BIPARK I

J. Ferreira, A. Lees, E. Tolosa, W. Poewe, A. Santos, N. Lopes, J.F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Symptom progression in a large cohort of Parkinson’s disease cases in a clinical practice setting

K. Markopoulou, A. Premkumar, B. Schoneburg, S. Walters, R. Frigerio, M. Szela, D.M. Maraganore (Glenview, IL, USA)
Symptomatic palatal and respiratory tremor with ataxia following fourth ventricle epidermoid cyst removal

B.R. Barton, B. Barton (Chicago, IL, USA)
Symptoms of dystonia in a mouse with mutation in Lamb1

K.J. Sweadner, Y.B. Liu, A. Tewari, J. Salameh, A. Brashear, L.J. Ozelius, K. Khodakhah (Boston, MA, USA)
Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach

E. Bereczki, R.M.M. Branca, P.T. Francis, J.H. Baek, J. Lehtio, D. Aarsland (Huddinge, Sweden)
Synaptic homeostasis in Parkinson’s disease: An high-density EEG study in different stage of the disease

S. Galati, S. Sarasso, C. Moeller, A. Kalein-Lang, C. Staedler (Lugano, Switzerland)
Syndrome of dystonia-parkinsonism is a complication of cyclosporine A treatment and may be irreversible

P. Miklavcic, S. Avcin, J. Jazbec, T. Vipotnik Vesnaver, B. Todorova, M. Trost, M. Kojovic (Ljubljana, Slovenia)
Synergistic effects of physical therapy and botulinum toxin in primary cervical dystonia

W. Hu, V. Rundle-Gonzalez, S.J. Kulkarni, L. Almeida, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)
Systematic literature review of droxidopa in clinical trials for neurogenic orthostatic hypotension (nOH) in parkinsonism

S. Tashiro, K. Dashtipour, J.J. Chen, K. Frei, E. Rashidian (Loma Linda, CA, USA)
Systematic literature review of quetiapine for hallucinosis / psychosis in Parkinson’s disease (PD)

K. Dashtipour, J.J. Chen, L. Massihi, S. Tashiro, K. Frei (Loma Linda, CA, USA)
Systematic review and meta-analysis of randomized controlled trials to evaluate placebo response in restless legs syndrome

F.B. Rodrigues, M. Silva, G.S. Duarte, R. Camara, R. Fernandes, D. Abreu, J. Costa, J.J. Ferreira (Lisboa, Portugal)
Systematic review of autosomal recessive parkinsonism using the MDGene database protocol

C. Hartmann, A. Mashychev, A. Westenberger, A. Domingo, J. Hampf, S. Schaake, H. Zehnle, C. Marras, L. Bertram, M. Kasten, K. Lohmann, C.M. Lill, C. Klein (Lübeck, Germany)
Systems biological approach to Parkinson’s disease- Uncovering effects of PD on the synapse

K.F. Heil, O. Sorokina, J.D. Armstrong, J. Hellgren Kotaleski (Edinburgh, United Kingdom)